Light chain cardiomyopathy: Structural analysis of the light chain tissue deposits

American Journal of Pathology

Volumn 148, Issue 5, 1996, Pages 1397-1406

  Gallo, Gloria ^a   Goñi, Fernando ^a   Boctor, Fuoad ^a   Vidal, Ruben ^a   Kumar, Asok ^a   Stevens, Fred J ^b   Frangione, Blas ^a   Ghiso, Jorge ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b ARGONNE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENCE JONES PROTEIN; IMMUNOGLOBULIN LIGHT CHAIN;

ADULT; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; BASEMENT MEMBRANE; CARDIOMYOPATHY; CASE REPORT; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN DEPOSITION; IMMUNOHISTOCHEMISTRY; ISOELECTRIC POINT; MALE; MYELOMA; PLASMA CELL; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STRUCTURE; SEQUENCE ANALYSIS;

ADULT; AMINO ACID SEQUENCE; AMINO ACIDS; BENCE JONES PROTEIN; CARDIOMYOPATHIES; HUMANS; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOHISTOCHEMISTRY; ISOELECTRIC POINT; MALE; MICROSCOPY, ELECTRON; MOLECULAR SEQUENCE DATA; MULTIPLE MYELOMA; MYOCARDIUM;

EID: 0029939217     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Gallo G, Picken M, Buxbaum J, Frangione B: The spectrum of monoclonal immunoglobulin deposition disease associated with immunocytic dyscrasias Semin Hematol 1989, 26.234-245
2. Randall RE, Wilhamson WC Jr, Mullinax F, Tung MY, Still MJ Manifestations of systemic light chain deposition Am J Med 1976, 60:293-299
3. Staros E, Katz SM: Myocardial necrosis in light chain deposition. Am Heart J 1985, 110:1295-1296
4. Peng SK, French WJ, Cohen AH, Fausel RE. Light chain cardiomyopathy associated with small vessel disease Arch Pathol Lab Med 1988, 112.844-846
5. McAllister HA Jr, Seger J, Bossart M, Ferrans VJ: Restrictive cardiomyopathy with κ light chain deposits in myocardium as a complication of multiple myeloma histochemical and electron microscopic observations Arch Pathol Lab Med 1988, 112 1151-1154
6. Toyoda M, Kajita A, Kita S, Osamura Y, Shinoda T. An autopsy case of diffuse myelomatosis associated with systemic light chain deposition disease (LCDD): a patho-anatomical, immunohistochemical and immunobiochemical study Acta Pathol Jpn 1988, 38:479-488
7. Scully RE, Galdabini JJ, McNeely BU: Case records of the Massachusetts General Hospital case I-1981 N Engl J Med 1981, 304 33-43
8. Cogne M, Silvain C, Khamlichi AA, Preud'homme JL Structurally abnormal immunoglobulins in human immunoproliferative disorders Blood 1992, 79.2181-2195
9. Ivanyi B Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma. Arch Pathol Lab Med 1990, 114.986-997
10. Cogne M, Preud'homme JL, Bauwens M, Touchard G, Aucouturier P: Structure of a monoclonal κ chain of the V-κ IV subgroup in the kidney and plasma cells in light chain deposition disease. J Clin Invest 1991, 87:2186-2190
11. Khamlichi AA, Aucouturier P, Silvain C, Bauwens M, Touchard G, Preud'homme J-L, Nau F, Cogne M: Primary structure of a monoclonal κ chain in myeloma with light chain deposition disease. Clin Exp Immunol 1992, 87:122-126
12. I subgroup (ISE) in light chain deposition disease. Clin Exp Immunol 1993, 91: 506-509
13. Aucouturier P, Khamlichi AA, Touchard G, Justrabo E, Cogne M, Chauffert B, Martin F, Preud'homme JL: Heavy-chain deposition disease N Engl J Med 1993, 329:1389-1393
14. I light chain subgroup, biochemical characterization Am J Pathol 1989. 134:749-754
15. Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C. Human κ light chain subgroup I. Sequences of Proteins of Immunological Interest. Bethesda, MD, National Institutes of Health, 1991, pp 103-112
16. Epp O, Lattman EE, Schiffer M, Huber R, Palm W: The molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI refined at 2 0-Å resolution Biochemistry 1975, 14 4943-4952
17. Chothia C, Lesk AM: Canonical structure for the hypervariable regions of the immunoglobulins J Mol Biol 1987, 196:901-917
18. Gallo G, Wisniewski T, Choi-Miura NH, Ghiso J, Frangione B. Potential role of apolipoprotein E in fibrillogenesis. Am J Pathol 1994, 145 526-530
19. Yang GCH, Nieto R, Stachura I, Gallo GR: Ultrastructural immunohistochemical localization of polyclonal IgG, C3, and amyloid P component on the Congo red-negative amyloid-like fibrils in fibrillary glomerulopathy Am J Pathol 1992, 141:409-419
20. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227 680-685
21. Towbin H, Staehelin T, Gordon J Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. procedure and some applications. Proc Natl Acad Sci USA 1979, 76 4350-4354
22. Matsudaira P Sequence from picomole quantities of proteins electroblotted onto polyvmylidine difluoride membranes J Biol Chem 1987, 262:10035-10038
23. Skoog B, Wichman A: Calculation of the isoelectric points of polypeptides from the amino-acid composition Trends Anal Chem 1986, 82-83
24. Schiffer M, Wu TT, Kabat EA: Subgroups of variable region genes of β chains of T-cell receptors for antigen. Proc Natl Acad Sci USA 1986, 83:4461-4463
25. Hurle MR, Helms LR, Li L, Chan W, Wetzel R: A role for destabilizing amino acid replacements in light chain amyloidosis. Proc Natl Acad Sci USA 1994, 91:5446-5450
26. Eulitz M, Linke RP: Primary structure of the variable part of an amyloidogenic Bence-Jones protein (MEV) an unusual insertion in the third hypervariable region of a human κ immunoglobulin light chain. Hoppe-Seyler's Z Physiol Chem 1982, 363:1347-1358
27. Klien R, Jaenichen R, Zachau HG: Expressed human immunoglobulin κ genes and their hypermutation. Eur J Immunol 1993, 23:3248-3271
28. Kyle RA, Gertz MA: Primary systemic amyloidosis clinical and laboratory features in 474 cases. Semin Hematol 1995, 32:45-49
29. Kanwar YS, Farquhar MG: Anionic sites in the glomerular basement membrane: in vivo and in vitro localization to the laminae rarae by cationic probes. J Cell Biol 1979, 81:137-153
30. Gallo GR, Caulin-Glaser T, Lamm ME: Charge of circulating immune complexes as a factor in glomerular basement membrane localization in mice. J Clin Invest 1981, 67:1305-1313
31. Kanwar YS, Farquhar MG: Presence of heparan sulfate in glomerular basement membrane. Proc Natl Acad Sci USA 1979, 76 1303-1307
32. Makino H, Gibbons JT, Reddy MK, Kanwar YS. Nephrogenicity of antibodies to proteoglycans of the glomerular basement membrane. J Clin Invest 1986, 77:142-156
33. Bellotti V, Merlini G, Bucciarelli E, Perfetti V, Quaglini S, Ascari E: Relevance of class, molecular weight and isoelectric point in predicting human light chain amyloidogenicity Br J Haematol 1990, 74.65-69
34. Stevens FJ, Myatt EA, Chang C-H, Westholm FA, Eulitz M, Weiss DT, Murphy C, Solomon A, Schiffer MA: A molecular model for self-assembly of amyloid fibrils immunoglobulin light chains. Biochemistry 1995, 34: 10697-10702
35. Murphy BF, Davies DJ, Morrow W, d'Apice AJ: Localization of terminal complement components S-protein and SP-40,40 in renal biopsies. Pathology 1989, 21:275-278
36. May PC, Finch CE: Sulfated glycoprotein 2. new relationships of this multifunctional protein to neurodegeneration Trends Neurosci 1992, 15:391-396
37. Solomon A, Weiss DT, Kattine AA: Nephrotoxic potential of Bence Jones proteins. N Engl J Med 1991, 324.1845-1851
38. Dwulet FE, O'Connor TF, Benson MD: Polymorphism in a κ I primary (AL) amyloid protein (BAN). Mol Immunol 1986, 23 73-78
39. Ganeval D, Noel LH, Preud'homme JL, Droz D, Grunfeld JP Light-chain deposition disease: its relation with AL-type amyloidosis. Kidney Int 1984, 26.1-9
40. Soto C, Frangione B: Two conformational states of amyloid β-peptide. implication for the pathogenesis of Alzheimer's disease. Neurosci Lett 1995. 186.115-118